Calliditas Therapeutics reports initial data for Phase 2a setanaxib trial in Alport syndrome

Innate Pharma cleared by FDA to launch TELLOMAK 3 Phase 3 trial of lacutamab in CTCL

AN2 Therapeutics partners with GSK to develop boron-based TB therapies; Secures Gates Foundation funding

Revvity agrees to acquire ACD/Labs to strengthen scientific software offerings

Akeso reveals preclinical research data for novel antagonistic monoclonal antibody aimed at IL-1RAP (AK135)

SanegeneBio signs global research and licensing collaboration with Eli Lilly

Rona Therapeutics reveals RN0361 phase one clinical data at American Heart Association 2025 Scientific Sessions

Sanofi and Regeneron's Dupixent meets all endpoints in pivotal AFRS study; sBLA accepted for FDA priority review

MavriX Bio reports first patient dosed in Phase 1/2 trial of MVX-220 for AS

Johnson & Johnson's DARZALEX FASPRO receives US FDA approval

Calico Life Sciences' ABBV-CLS-628S granted US FDA Orphan Drug Designation

Lunai Bioworks publishes breakthrough on second-generation allogeneic dendritic cell therapy in vaccines

Oxford Nanopore and bioMérieux introduce AmPORE-TB for rapid tuberculosis resistance characterisation

Cizzle Biotechnology signs Letter of Intent with UK diagnostic provider

HUTCHMED completes enrollment of global Phase III SAFFRON trial for ORPATHYS and TAGRISSO combination in lung cancer